Sigmoid-vaginal fistula during bevacizumab treatment diagnosed by fistulography

J Clin Pharm Ther. 2016 Dec;41(6):725-726. doi: 10.1111/jcpt.12454. Epub 2016 Sep 13.

Abstract

What is known and objective: There have been several reports describing rectovaginal fistula development after bevacizumab treatment, and these fistulas were diagnosed by CT scan or colonoscopy. We report a case of sigmoid-vaginal fistula diagnosed by fistulography.

Case description: The case is a 53-year-old woman who was treated for chronic myelogenous leukaemia and gynaecological cancers 8 years previously. At 52 years of age, she was diagnosed with colon cancer and had a partial colectomy performed. One year after surgery, colon cancer recurred, and she was treated with anticancer agents, including bevacizumab. During chemotherapy, she complained of a foul smelling discharge from the vagina. Fistulography revealed a sigmoid-vaginal fistula.

What is new and conclusion: This is the first report of vaginal fistulography performed on a patient who was treated with bevacizumab. Fistulography may be useful for detecting sigmoid-vaginal fistula.

Keywords: bevacizumab; fistulography; sigmoid-vaginal fistula.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / adverse effects*
  • Bevacizumab / therapeutic use
  • Colon, Sigmoid / drug effects*
  • Colonic Neoplasms / drug therapy
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Vaginal Fistula / chemically induced*

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab